Raymond James Financial Inc. Acquires Shares of 244,854 Aspen Aerogels, Inc. (NYSE:ASPN)

Raymond James Financial Inc. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 244,854 shares of the construction company’s stock, valued at approximately $2,909,000.

A number of other large investors have also made changes to their positions in the company. Journey Strategic Wealth LLC bought a new stake in shares of Aspen Aerogels during the fourth quarter worth $178,000. Ballentine Partners LLC increased its holdings in Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock worth $189,000 after buying an additional 2,565 shares during the last quarter. Aigen Investment Management LP bought a new stake in Aspen Aerogels during the fourth quarter worth $219,000. IFP Advisors Inc lifted its stake in Aspen Aerogels by 6,923.4% in the fourth quarter. IFP Advisors Inc now owns 20,719 shares of the construction company’s stock valued at $246,000 after acquiring an additional 20,424 shares during the last quarter. Finally, Talbot Financial LLC bought a new position in Aspen Aerogels during the fourth quarter worth about $251,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ASPN. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. B. Riley cut their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, March 11th. Roth Mkm reduced their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Finally, Barclays cut their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $19.11.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $6.60 on Friday. The company has a market cap of $541.48 million, a PE ratio of 41.22 and a beta of 2.28. Aspen Aerogels, Inc. has a one year low of $6.55 and a one year high of $33.15. The stock has a 50-day moving average of $9.04 and a 200-day moving average of $14.77. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, equities research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.